Cargando…
The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396103/ https://www.ncbi.nlm.nih.gov/pubmed/36016752 http://dx.doi.org/10.21037/hbsn-22-146 |
| _version_ | 1784771855461122048 |
|---|---|
| author | Yang, Yinmo Tian, Xiaodong |
| author_facet | Yang, Yinmo Tian, Xiaodong |
| author_sort | Yang, Yinmo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9396103 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93961032022-08-24 The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”? Yang, Yinmo Tian, Xiaodong Hepatobiliary Surg Nutr Editorial AME Publishing Company 2022-08 /pmc/articles/PMC9396103/ /pubmed/36016752 http://dx.doi.org/10.21037/hbsn-22-146 Text en 2022 Hepatobiliary Surgery and Nutrition. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Yang, Yinmo Tian, Xiaodong The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”? |
| title | The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”? |
| title_full | The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”? |
| title_fullStr | The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”? |
| title_full_unstemmed | The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”? |
| title_short | The management strategy of pancreatic cancer in the era of systemic therapy—“Surgery First” or “Surgery Last”? |
| title_sort | management strategy of pancreatic cancer in the era of systemic therapy—“surgery first” or “surgery last”? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396103/ https://www.ncbi.nlm.nih.gov/pubmed/36016752 http://dx.doi.org/10.21037/hbsn-22-146 |
| work_keys_str_mv | AT yangyinmo themanagementstrategyofpancreaticcancerintheeraofsystemictherapysurgeryfirstorsurgerylast AT tianxiaodong themanagementstrategyofpancreaticcancerintheeraofsystemictherapysurgeryfirstorsurgerylast AT yangyinmo managementstrategyofpancreaticcancerintheeraofsystemictherapysurgeryfirstorsurgerylast AT tianxiaodong managementstrategyofpancreaticcancerintheeraofsystemictherapysurgeryfirstorsurgerylast |